Paid Clinical Trials Vermont
Discover 205 paid clinical trials in Vermont. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Sponsor:
AstraZeneca
Location:
Code:
NCT06307665
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 12 - 17
Healthy Volunteers: Not accepted
Interventions
BDA MDI
AS MDI
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT05923073
Conditions
Crohn's Disease
Eligibility Criteria
Sex: All
Age: 2 - 17
Healthy Volunteers: Not accepted
Interventions
Guselkumab
A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.
Sponsor:
AstraZeneca
Location:
Code:
NCT06268873
Conditions
Chronic Kidney Disease and Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Baxdrostat/dapagliflozin
Dapagliflozin in combination with placebo
Efficacy of a Clinic-based, Multi- Disciplinary, Pediatric Weight Management Program
Sponsor:
University of Vermont
Location:
Code:
NCT01857791
Conditions
Body Weight Changes
Eligibility Criteria
Sex: All
Age: 12 - 18
Healthy Volunteers: Not accepted
Interventions
multidisciplinary, behavior modification
His-Bundle Corrective Pacing in Heart Failure
Sponsor:
University of Rochester
Location:
Code:
NCT05265520
Conditions
Right Bundle-Branch Block
Heart Failure
His-bundle Pacing
Cardiac Resynchronization Therapy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
His-CRT implantation
BIV-CRT implantation
Carbon Monoxide Monitoring and Emergency Treatment
Sponsor:
University of Vermont
Location:
Code:
NCT00841165
Conditions
Carbon Monoxide Poisoning
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Continuous Positive Airway Pressure
Non-rebreather oxygen mask
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Sponsor:
Sermonix Pharmaceuticals Inc.
Location:
Code:
NCT05696626
Conditions
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Lasofoxifene in combination with abemaciclib
Fulvestrant in combination with abemaciclib
Neuromuscular Electrical Stimulation in COPD/Community Acquired Pneumonia
Sponsor:
University of Vermont
Location:
Code:
NCT05452226
Conditions
Community-acquired Pneumonia
COPD Exacerbation Acute
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
neuromuscular electrical stimulation (NMES)
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT04530565
Conditions
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Blinatumomab
Bone Marrow Aspiration and Biopsy
Cyclophosphamide
Cytarabine
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Sponsor:
Children's Oncology Group
Location:
Code:
NCT05235165
Conditions
Metastatic Malignant Neoplasm in the Lung
Metastatic Osteosarcoma
Osteosarcoma
Eligibility Criteria
Sex: All
Age: 0 - 50
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Questionnaire Administration
Thoracoscopy
Thoracotomy